Bausch + Lomb Reports Q3 Growth and Highlights Dry Eye Diagnosis Gap

Bausch + Lomb released multinational research on October 30, 2026, revealing a gap between self-reported dry eye symptoms and formal diagnoses. The NESTS survey found up to 39% of respondents in five countries reported regular symptoms, compared to a maximum of 25% with healthcare professional diagnoses. Over 80% modified behavior due to symptoms, while up to one-quarter of those consulting professionals felt guidance was inadequate. This announcement coincides with strong third-quarter 2026 financial results reported on October 28, showing total revenue growth of 7% to US$1.375 billion. Pharmaceuticals grew 11%, driven by a 42% surge in MIEBO® revenue; Vision Care rose 5%; and Surgical increased 9%. Chairman Thomas J. Appio noted consistent delivery against commitments.